Drugs / TALVIRALINE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00002357 | — | HIV infectious disease | Hoechst Marion Roussel | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TALVIRALINE | ChEMBL registry synonym — accepted as the source's own label CHEMBL430488 ↗ |
| Known as | HBY 097 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002357 ↗ |
| Known as | Talviralina | ChEMBL registry synonym — accepted as the source's own label CHEMBL430488 ↗ |
| Modality | Small molecule | — CHEMBL430488 ↗ |